38 related articles for article (PubMed ID: 30345534)
21. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
22. The effects of aging on tumor growth and angiogenesis are tumor-cell dependent.
Reed MJ; Karres N; Eyman D; Cruz A; Brekken RA; Plymate S
Int J Cancer; 2007 Feb; 120(4):753-60. PubMed ID: 17131319
[TBL] [Abstract][Full Text] [Related]
23. Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
Ronca R; Alessi P; Coltrini D; Di Salle E; Giacomini A; Leali D; Corsini M; Belleri M; Tobia C; Garlanda C; Bonomi E; Tardanico R; Vermi W; Presta M
J Pathol; 2013 Jun; 230(2):228-38. PubMed ID: 23424081
[TBL] [Abstract][Full Text] [Related]
24. Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.
Wu CT; Hsieh CC; Lin CC; Chen WC; Hong JH; Chen MF
J Mol Med (Berl); 2012 Nov; 90(11):1343-55. PubMed ID: 22660275
[TBL] [Abstract][Full Text] [Related]
25. Versatile prostate cancer treatment with inducible caspase and interleukin-12.
Nikitina EY; Desai SA; Zhao X; Song W; Luo AZ; Gangula RD; Slawin KM; Spencer DM
Cancer Res; 2005 May; 65(10):4309-19. PubMed ID: 15899823
[TBL] [Abstract][Full Text] [Related]
26. IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.
Španko M; Strnadová K; Pavlíček AJ; Szabo P; Kodet O; Valach J; Dvořánková B; Smetana K; Lacina L
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681685
[TBL] [Abstract][Full Text] [Related]
27. A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth.
Yu SH; Maynard JP; Vaghasia AM; De Marzo AM; Drake CG; Sfanos KS
Prostate; 2019 Feb; 79(2):215-222. PubMed ID: 30345534
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 and prostate cancer progression.
Smith PC; Hobisch A; Lin DL; Culig Z; Keller ET
Cytokine Growth Factor Rev; 2001 Mar; 12(1):33-40. PubMed ID: 11312117
[TBL] [Abstract][Full Text] [Related]
29. IL-6 Signaling Link between Inflammatory Tumor Microenvironment and Prostatic Tumorigenesis.
Ene CV; Nicolae I; Geavlete B; Geavlete P; Ene CD
Anal Cell Pathol (Amst); 2022; 2022():5980387. PubMed ID: 35464825
[TBL] [Abstract][Full Text] [Related]
30. Obesity, Inflammation, and Advanced Prostate Cancer.
Olivas A; Price RS
Nutr Cancer; 2021; 73(11-12):2232-2248. PubMed ID: 33287566
[TBL] [Abstract][Full Text] [Related]
31. Complexity of Neural Component of Tumor Microenvironment in Prostate Cancer.
Sejda A; Sigorski D; Gulczyński J; Wesołowski W; Kitlińska J; Iżycka-Świeszewska E
Pathobiology; 2020; 87(2):87-99. PubMed ID: 32045912
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1 signaling in solid organ malignancies.
Dosch AR; Singh S; Nagathihalli NS; Datta J; Merchant NB
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188670. PubMed ID: 34923027
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
